Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001654954-24-012731
Filing Date
2024-10-07
Accepted
2024-10-07 07:32:15
Documents
3
Period of Report
2024-10-04

Document Format Files

Seq Description Document Type Size
1 FORM 6-K fsd_6k.htm 6-K 11690
2 PRESS RELEASE fsd_ex991.htm EX-99.1 17172
3 fsd_ex991img2.jpg GRAPHIC 7812
  Complete submission text file 0001654954-24-012731.txt   40955
Mailing Address FIRST CANADIAN PLACE 100 KING STREET WEST, SUITE 4000 TORONTO A6 M5X 1A4
Business Address FIRST CANADIAN PLACE 100 KING STREET WEST, SUITE 4000 TORONTO A6 M5X 1A4 (416) 854-8884
Quantum Biopharma Ltd. (Filer) CIK: 0001771885 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39152 | Film No.: 241356165
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)